Sorrento Therapeutics, Inc. (NASDAQ:SRNE, ", , Sorrento", , )))), a biopharmaceutical company dedicated to the development of life-saving therapeutics to treat cancer, intractable pain, and infectious disease,
As Nvidia Corporation prepares for its Q1 earnings release, opinions differ sharply between wealth manager Ross Gerber, who sees the stock as "fully valued," and Wedbush analyst Dan Ives, who anticipates significant growth driven by the AI revolution.